Nearly 2,000 people unknowingly living with HIV have been diagnosed by a pioneering NHS programme, which tests anyone needing a blood test in A&E, saving lives and preventing new infections, shows new ...

Hundreds of women with aggressive cervical cancer are to be offered a new immunotherapy on the NHS, which could help more women survive and stay cancer-free in the long-term. Pembrolizumab – which ...

All pharmacy contractors are offered the opportunity to sign up to this advanced service where they meet the requirements of this advanced service specification. Where a pharmacy contractor agrees to ...

Visits to the hay fever advice on the NHS website have more than doubled in the past week as temperatures rise this weekend. There have been 12,990 visits to the hay fever page on ...

The latest NHS England management data has shown the real life and immediate impact of the Medical Training Prioritisation Act. The Act came into force in March responding to concerns about increasing ...

Football fans are being urged not to ignore health problems, as new analysis reveals a significant drop in A&E attendances while the Three Lions are playing. Analysis of A&E attendance data during ...

A new life-changing treatment option – GLP-1 drug semaglutide known as Wegovy – is set to be available on the NHS within months, with 1.2 million people with cardiovascular disease eligible to receive ...

National Institute for Health and Care Excellence (NICE) recommends tirzepatide (Mounjaro®) for the management of obesity for certain patients. Tirzepatide (also called Mounjaro ®) is a weight loss ...

Weekly updates will commence on Thursday 4 December 2025, covering the week ending Sunday 30 November 2025, and will continue every Thursday at 09:30 throughout winter. The final publication will be ...

We have now published, for consultation, the draft 2026/27 NHS Standard Contract (both full length and shorter-form versions). The consultation paper describes the main, material changes we are ...

NHS England will commission icatibant for treatment of moderate to severe acute swellings due to bradykinin-mediated angioedema with normal C1 inhibitor in accordance with the criteria outlined in ...

Today we are setting out a bold, ambitious and necessary new course for the NHS, with ‘Fit for the Future’, our 10 Year Health Plan for England. Throughout our discussions over the last few months, we ...